Cargando…
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance
SIMPLE SUMMARY: Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer, is mostly associated with smoking and has a low survival rate. Among the different alterations in genes identified in SCLC, those related to the MYC family have emerged as highly relevant, alterations MYCN part...
Autores principales: | Bortolotti, Sonia, Angelucci, Silvia, Montemurro, Luca, Bartolucci, Damiano, Raieli, Salvatore, Lampis, Silvia, Amadesi, Camilla, Scardovi, Annalisa, Nieddu, Giammario, Cerisoli, Lucia, Paganelli, Francesca, Chiarini, Francesca, Teti, Gabriella, Falconi, Mirella, Pession, Andrea, Hrelia, Patrizia, Tonelli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913109/ https://www.ncbi.nlm.nih.gov/pubmed/36765949 http://dx.doi.org/10.3390/cancers15030990 |
Ejemplares similares
-
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
por: Lampis, Silvia, et al.
Publicado: (2022) -
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
por: Bartolucci, Damiano, et al.
Publicado: (2022) -
MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma
por: Raieli, Salvatore, et al.
Publicado: (2021) -
Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs
por: Bartolucci, Damiano, et al.
Publicado: (2022) -
Implication of Cellular Senescence in Osteoarthritis: A Study on Equine Synovial Fluid Mesenchymal Stromal Cells
por: Teti, Gabriella, et al.
Publicado: (2023)